In vivo mapping of cellular resolution neuropathology in brain ischemia with diffusion MRI.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 39018390.
- Also identified by DOI 10.1126/sciadv.adk1817 and PMC identifier 466947.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Noninvasive mapping of cellular pathology can provide critical diagnostic and prognostic information. Recent advances in diffusion magnetic resonance imaging enabled in vivo examination of tissue microstructures well beyond the imaging resolution. Here, we proposed to use diffusion time-dependent diffusion kurtosis imaging (<i>t</i>DKI) to simultaneously assess cellular morphology and transmembrane permeability in hypoxic-ischemic (HI) brain injury. Through numerical simulations and organoid imaging, we demonstrated the feasibility of capturing effective size and permeability changes using <i>t</i>DKI. In vivo MRI of HI-injured mouse brains detected a shift of the <i>t</i>DKI peak to longer diffusion times, suggesting swelling of the cellular processes. Furthermore, we observed a faster decrease of the <i>t</i>DKI tail, reflecting increased transmembrane permeability associated with up-regulated water exchange or necrosis. Such information, unavailable from a single diffusion time, can predict salvageable tissues. Preliminary applications of <i>t</i>DKI in patients with ischemic stroke suggested increased transmembrane permeability in stroke regions, illustrating <i>t</i>DKI's potential for detecting pathological changes in the clinics.
Medical subject headings
- Diffusion Magnetic Resonance Imaging
- Brain Ischemia